Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems

摘要: Biocompatible intraocular drug delivery systems include a carbonic anhydrase inhibitor therapeutic agent and polymeric component in the form of an implant, microparticle, plurality implants or microparticles, combinations thereof. The is released biologically active form, for example, may retain its three dimensional structure when into eye patient, have altered three. be placed to treat reduce occurrence one more ocular conditions, such as retinal damage, including glaucoma proliferative vitreoretinopathy among others.